Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00138203
Status:
COMPLETED
Last Update Posted:
2018-01-30
First Post:
2005-08-29
Brief Title:
Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB Stage IV or Recurrent Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Non-small Cell Lung Cancer |
| Recurrent Non-small Cell Lung Cancer |
| Stage IIIB Non-small Cell Lung Cancer |
Keywords: